📈 69% of S&P 500 stocks beating the index - a historic record! Pick the best ones with AI.See top stocks

Aclaris Therapeutics Inc (ACRS)

NASDAQ
Currency in USD
Disclaimer
1.150
-0.040(-3.36%)
Closed
After Hours
1.1500.000(0.00%)

ACRS Comments

7$ buy and 12$ stop this week
Textbook pump and dump. "Pump and dump" (P&D) is a form of securities fraud that involves artificially inflating the price of an owned stock through false and misleading positive statements, in order to sell the cheaply purchased stock at a higher price. Once the operators of the scheme "dump" (sell) their overvalued shares, the price falls and investors lose their money.
based on the very wealthy berg that I know pushing this...it's absolutely a pump and dump.
was up by 200%. What do you think now ? It's still holding $17 is a surprise. Not gonna hold here for long.
Why? Do you know anything about this company? The comments on this investing app are always remedial. Come to this app if you want CNN BS
17 tomorrow
should i buy this stock right know ???
should i buy this stock right know ???
why that much up????
Do your homework. Like a good citizen who pays back to his country daily, instead of expecting from it, be proactive, learn, research, be aware and educated - so when you come to invest, you make better decisions and not like those lousy losers who stormed the capitol - don't be a loser!
😳
small company easy control the price by big shark
I shorted this rocket, RIP my portfolio.
 i would not touch it now, it is all spec right now
i have 400 of them on $16.20, already make $4000
i didnt read the news and i thought it was one of those pump and dump, then i got all rock headed and got myself burned, i pulled out on 16 so im not at a total loss.
my broker stop accept for trade this stock
i am out on $16.20 :)
$16 in next 15 min, and i get in $12
OMG, rocket
what happened?
they got FDA approval
Nothing exciting is going to happen with this company until their topical JAK inhibitors are approved for hair loss and vitiligo in 2020 so I’m not sure why the constant hammering by analysts. I’m actualy a dermatologist. We have zero effective and safe treatments for alopecia areata or vitiligo at present. If it also is effective to treat androgenic alopecia that’s also really big. The founder is the same derm who sold Kybella to Allergan for a couple of billion.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.